| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Marshak Richard Chief Commercial Officer | Sale | -543 | -0.43%125,101 | $2.67 | $1,450 | View SEC filing | |
| 2026-05-18 | Wahlstrom Mats Director | Purchase | +60,000 | +68.53%147,555 | $2.53 | $151,800 | View SEC filing | |
| 2026-05-18 | Stansky Michael P Director | Purchase | +610,000 | +59.20%1,640,420 | $2.50 | $1,525,000 | View SEC filing | |
| 2026-05-18 | Szela Mary T CEO and President | Purchase | +39,682 | +3.87%1,065,215 | $2.59 | $102,776 | View SEC filing | |
| 2026-05-18 | Patience David Chief Financial Officer | Purchase | +7,100 | +2.64%275,757 | $2.43 | $17,253 | View SEC filing | |
| 2026-05-18 | Gordon Gary B. Director | Purchase | +10,000 | +16.00%72,510 | $2.46 | $24,600 | View SEC filing | |
| 2026-03-20 | Devlin Jodi Chief of Clinical Operations | Sale | -3,207 | -3.19%97,364 | $4.11 | $13,171 | View SEC filing | |
| 2026-03-20 | Cox Bryan F. Chief of Research | Sale | -3,184 | -1.91%163,415 | $4.11 | $13,085 | View SEC filing | |
| 2026-03-20 | Marshak Richard Chief Commercial Officer | Sale | -3,457 | -3.04%110,397 | $4.11 | $14,210 | View SEC filing | |
| 2026-03-20 | Stevens Jennifer Chief Regulatory Officer | Sale | -3,530 | -2.77%124,110 | $4.11 | $14,509 | View SEC filing | |
| 2026-03-20 | Szela Mary T CEO and President | Sale | -20,302 | -2.63%752,987 | $3.91 | $79,383 | View SEC filing | |
| 2026-02-23 | Patience David Chief Financial Officer | Purchase | +3,657 | +1.38%268,657 | $4.10 | $14,994 | View SEC filing | |
| 2026-02-23 | Gordon Gary B. Director | Purchase | +9,756 | +100.00%9,756 | $4.10 | $40,000 | View SEC filing | |
| 2026-02-23 | Valle William Director | Purchase | +30,487 | +100.00%30,487 | $4.10 | $124,997 | View SEC filing | |
| 2026-02-23 | Szela Mary T CEO and President | Purchase | +30,487 | +4.10%773,289 | $4.10 | $124,997 | View SEC filing | |
| 2026-02-23 | Stansky Michael P Director | Purchase | +361,098 | +57.71%986,830 | $4.10 | $1,480,502 | View SEC filing | |
| 2025-05-21 | Cox Bryan F. Chief of Research | Sale | -4,764 | -3.84%119,415 | $5.18 | $24,678 | View SEC filing | |
| 2025-05-21 | Devlin Jodi Chief of Clinical Operations | Sale | -4,764 | -8.28%52,764 | $5.18 | $24,678 | View SEC filing | |
| 2025-05-21 | Marshak Richard Chief Commercial Officer | Sale | -6,597 | -8.71%69,101 | $5.18 | $34,172 | View SEC filing | |
| 2025-05-21 | Stevens Jennifer Chief Regulatory Officer | Sale | -8,704 | -10.08%77,640 | $5.18 | $45,087 | View SEC filing | |
| 2025-02-06 | Young James Emmett Chief Financial Officer | Purchase | +6,000 | +25.00%30,000 | $5.65 | $33,900 | View SEC filing | |
| 2025-01-31 | Szela Mary T CEO AND PRESIDENT | Purchase | +10,040 | +2.31%444,259 | $5.15 | $51,754 | View SEC filing | |
| 2025-01-29 | Szela Mary T CEO AND PRESIDENT | Purchase | +9,542 | +2.25%434,219 | $5.27 | $50,303 | View SEC filing | |
| 2025-01-29 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Purchase | +30,000 | +17.89%197,732 | $5.24 | $157,200 | View SEC filing | |
| 2025-01-29 | Young James Emmett Chief Financial Officer | Purchase | +24,000 | +100.00%24,000 | $5.40 | $129,600 | View SEC filing |
1-25 of 33
